Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

INOMAX

NITRIC OXIDE

Standard Dose
100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview INOMAX is listed in Drugs@FDA under application 020845 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient NITRIC OXIDE Form and strength GAS;INHALATION - 100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MALLINCKRODT IRELAND Submission history Latest submission status date: 2023-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview INOMAX is listed in Drugs@FDA under application 020845 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient NITRIC OXIDE Form and strength GAS;INHALATION - 100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MALLINCKRODT IRELAND Submission history Latest submission status date: 2023-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
INOMAX (NITRIC OXIDE) | Drug Monograph | MedicHelpline